CJC-1295 (No DAC) Storage Temperature Guide (-20C to Room Temp)

Chemical Structure and Thermal Vulnerability of CJC-1295 (No DAC)

CJC-1295 (No DAC), also recognized in biochemical literature as Modified GRF 1-29, is a 29-amino-acid synthetic peptide analog of endogenous growth hormone-releasing hormone (GHRH). By substituting specific amino acids at positions 2, 8, 15, and 27 (specifically D-Ala2, Gln8, Ala15, and Leu27), the peptide exhibits enhanced resistance to enzymatic cleavage by dipeptidyl peptidase-IV (DPP-IV) relative to native GHRH 1-29. In preclinical models, it functions as a targeted GHRH receptor agonist, investigated for its ability to stimulate pulsatile growth hormone (GH) secretion and subsequently elevate downstream insulin-like growth factor 1 (IGF-1) levels for tissue repair research.

Despite these structural modifications that extend enzymatic half-life in vitro and in vivo, the physical peptide chain remains vulnerable to non-enzymatic chemical degradation when exposed to thermal stress. Peptide degradation kinetics follow the Arrhenius equation: higher temperatures provide the thermal energy necessary to accelerate degradation pathways such as deamidation, peptide bond hydrolysis, oxidation of susceptible residues, and molecular aggregation. For laboratory researchers utilizing CJC-1295 (No DAC), establishing controlled storage temperatures is vital to ensure experimental reproducibility and prevent loss of receptor-binding affinity.

Primary Degradation Pathways Under Thermal Stress

When stored above recommended temperature thresholds, CJC-1295 (No DAC) undergoes several distinct degradation pathways that alter its primary and secondary structures. High ambient temperatures supply kinetic energy that disrupts the non-covalent interactions maintaining secondary conformation, leading to partial unfolding and exposure of reactive side-chain sites.

Deamidation represents one of the primary degradation routes, occurring predominantly at asparagine (Asn) and glutamine (Gln) residues. At elevated temperatures and neutral-to-alkaline pH, these side-chain amides form a cyclic succinimide intermediate that hydrolyzes into a mixture of isoaspartic and aspartic acid residues. This structural alteration changes the overall net charge of the molecule, which can be identified via High-Performance Liquid Chromatography (HPLC) and Liquid Chromatography-Mass Spectrometry (LC-MS). Additionally, methionine (Met) or tryptophan (Trp) residues within synthetic sequences are prone to oxidation under ambient thermal conditions when exposed to dissolved oxygen, yielding sulfoxide derivatives.

Hydrolysis of the backbone peptide bonds is another major concern in aqueous solutions exposed to ambient or elevated temperatures. Water molecules act as nucleophiles, breaking peptide bonds and forming truncated fragments that lack binding activity at the GHRH receptor. Furthermore, partially unfolded peptides in solution tend to aggregate into insoluble dimers and higher-order oligomers via hydrophobic interactions, rendering the sample unsuitable for analytical assays.

Lyophilized Powder Storage Parameters: Room Temp to -80°C

In its lyophilized (freeze-dried) state, CJC-1295 (No DAC) exhibits significantly higher thermal stability than in solution, as the removal of free water minimizes hydrolytic degradation. However, temperature management remains critical to preserving long-term purity and preventing subtle chemical shifts over extended storage periods.

Room Temperature (20°C to 25°C): Lyophilized CJC-1295 (No DAC) demonstrates short-term stability at ambient laboratory temperatures. In vitro stability assays indicate that high-purity lyophilized cake maintains acceptable purity levels (typically >98%) for up to 3 to 4 weeks at ambient conditions, provided the vial remains sealed in a dry environment protected from direct light. Ambient exposure should generally be limited to shipping transit times or short handling windows.

Refrigerated (2°C to 8°C): When stored under standard refrigeration, the lyophilized peptide remains stable for approximately 12 to 18 months. Refrigeration significantly slows down background oxidation and deamidation, making it an acceptable storage method for medium-term research projects.

Standard Freezer (-20°C): Storing lyophilized CJC-1295 (No DAC) at -20°C is the recommended standard protocol for long-term preservation up to 24 to 36 months. At -20°C, molecular motion is drastically reduced, effectively halting non-enzymatic degradation pathways and maintaining peak compound integrity.

Ultra-Low Temperature Freezer (-80°C): For long-term biobanking or multi-year comparative studies, storage in an ultra-low temperature freezer (-80°C) offers maximum preservation. In these conditions, lyophilized peptides can remain stable for 48 months or more without measurable loss of analytical purity.

Reconstituted State Stability and Temperature Windows

Once reconstituted into aqueous solution, CJC-1295 (No DAC) becomes far more susceptible to hydrolytic cleavage, deamidation, and microbial proliferation. Researchers must adjust handling protocols immediately following solubilization.

When reconstituted with sterile Bacteriostatic Water (containing 0.9% benzyl alcohol as a preservative), the solution should be stored under refrigeration at 2°C to 8°C. Under these conditions, the reconstituted peptide maintains structural integrity for up to 21 to 28 days. Prior to running specialized assays, researchers can consult a reconstitution calculator to determine precise molar concentrations while maintaining liquid volume limits suitable for small-vial storage.

Reconstitution in plain Sterile Water for Injection (without preservative) severely restricts the stable window. Unpreserved aqueous solutions stored at 2°C to 8°C should be utilized within 24 to 48 hours to prevent potential bacterial contamination and rapid hydrolytic degradation.

Reconstituted liquid solutions of CJC-1295 (No DAC) should never be subjected to repeated freeze-thaw cycles. Freezing liquid peptide solutions causes ice crystal formation and local concentration spikes (cryo-concentration), which induce shear stress and trigger peptide aggregation upon thawing. If long-term liquid storage is required, single-use aliquots should be frozen rapidly once at -20°C or -80°C and thawed immediately prior to experimental application.

Transit Excursions and Cold-Chain Resilience

A common concern for laboratory logistics is temperature exposure during transit. Lyophilized CJC-1295 (No DAC) is formulated with protective lyoprotectants (such as mannitol or trehalose) during the freeze-drying process to stabilize the tertiary matrix during temporary shipping fluctuations.

Preclinical stability testing demonstrates that short-term thermal excursions up to 37°C for 48 to 72 hours do not cause significant peptide degradation in high-purity lyophilized samples. To guarantee minimal risk of degradation during delivery, PX1 Research dispatches research compounds using temperature-aware packaging from facility hubs in California and Arizona. Same-day shipping (Monday–Friday) ensures rapid delivery, reducing potential thermal stress before the compound reaches the laboratory cold storage infrastructure.

Analytical Verification of Purity Following Thermal Exposure

To verify that storage conditions have preserved the peptide's structural integrity, laboratories can perform analytical validation using High-Performance Liquid Chromatography (HPLC) coupled with Mass Spectrometry (MS). Reverse-Phase HPLC (RP-HPLC) separates intact CJC-1295 (No DAC) from degradation products such as deamidated species, oxidized fragments, or aggregate complexes based on hydrophobic interactions.

Every batch of compound supplied by PX1 Research includes a batch-specific, third-party CoA (Certificate of Analysis) generated by an ISO 17025 accredited laboratory. Validated metrics include HPLC purity (>98%), MS mass identity confirmation, and kinetic chromogenic LAL testing to verify endotoxin levels remain below regulatory limits (<0.01 EU/mg). Comparing post-storage HPLC chromatograms against the baseline COA allows researchers to quantify any degradation that may have occurred due to improper storage management.

Comparative Stability: CJC-1295 (No DAC) vs. Class Analogs

Within the broader category of growth hormone secretagogues, structural differences significantly alter thermal and enzymatic stability. Comparing CJC-1295 (No DAC) against related compounds highlights how chemical modifications influence storage requirements.

While CJC-1295 (No DAC) requires strict refrigeration post-reconstitution due to its bare C-terminus, CJC-1295 DAC incorporates a Drug Affinity Complex (maleimidopropionic acid) that covalently binds to circulating albumin in vivo. While this modification extends systemic half-life in animal models, the un-bound lyophilized DAC raw material exhibits comparable thermal degradation rates to CJC-1295 (No DAC) at elevated temperatures. Non-peptidic or cyclic secretagogues such as Ipamorelin and GHRP-6 demonstrate slightly higher resistance to hydrolytic backbone cleavage in solution due to their pentapeptide or hexapeptide structures, yet all GHRH analogs and GHRPs still require cold storage once reconstituted to prevent oxidation and bacterial growth. Exploring the complete catalog of all peptides allows researchers to compare analytical specifications across distinct secretagogue classes.

Storage Decision Matrix by Study Duration

Selecting the appropriate storage temperature depends directly on the planned timeline of the research protocol. The following decision framework guides laboratory inventory management for CJC-1295 (No DAC):

1. Immediate Testing (< 7 Days): Lyophilized powder may be held at ambient room temperature (20°C–25°C) in a desiccated, dark cabinet. Reconstituted solution (in bacteriostatic water) should remain refrigerated at 2°C–8°C. 2. Short-Term Study (1 to 4 Weeks): Lyophilized powder should be stored under standard refrigeration (2°C–8°C). Reconstituted solution must be held at 2°C–8°C and used within 28 days. 3. Medium-Term Project (1 to 12 Months): Lyophilized powder must be stored in a standard freezer at -20°C. Reconstituted aliquots should be single-thawed only if liquid storage is unavoidable. 4. Long-Term Repository (1 to 3+ Years): Lyophilized powder must be kept in an ultra-low freezer at -20°C to -80°C. Vials should be sealed with parafilm and placed inside a desiccated secondary container to prevent moisture ingress during freezer defrost cycles.

Best Practices for Laboratory Handling and Storage

To ensure maximum reproducibility and prevent environmental degradation during storage, research personnel should follow established laboratory protocols for peptide handling.

First, minimize condensation during storage access. When retrieving lyophilized vials from cold storage (-20°C or -80°C), allow the sealed vial to equilibrate to room temperature on the benchtop for 30 to 60 minutes before opening the cap. Opening a cold vial in ambient air causes atmospheric moisture to condense rapidly onto the desiccated powder, accelerating hydrolysis upon reconstitution.

Second, protect the compound from light exposure. CJC-1295 (No DAC) is light-sensitive; UV and direct visible light can catalyze photo-oxidation of aromatic amino acid residues. Store vials in amber containers or opaque boxes. Finally, ensure all long-term bulk procurement through PX1 Research is logged in institutional inventory management systems with lot-specific COA records to maintain traceable quality assurance standards across multi-phase preclinical trials.